The report on the Global Biomarkers Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Drivers
- Rising value of biomarkers for diagnostic purposes
- Increasing efforts toward drug discovery
- Growing healthcare industry
Restraints
- Expensive treatment
- Return on investment is low
- Unfavorable reimbursement policy
Report includes a detailed analysis on value chain in order to provide a holistic view of the biomarkers market. Value chain analysis comprises detailed evaluation of the roles of various players involved in the biomarkers industry, from raw material suppliers to end-users.
Biomarkers market attractiveness analysis has been included in order to analyze the application segments that are estimated to be lucrative during the forecast period on the basis of their market size and growth rate. Attractiveness of the market has been derived from market size, profit margin, growth rate, availability of raw materials, competition, and other factors such as social and legal constraints.
The biomarkers market has further been segmented based on product such as consumables, services and software. The study provides forecast and estimates market for each product in terms of revenue during the forecast period. Each product has been further analyzed based on regional and country levels in terms of revenue.
The biomarkers market has further been segmented based on type such as safety biomarkers, efficacy biomarkers and validation biomarkers. Efficacy biomarkers market is further segmented as predictive biomarkers, surrogate biomarkers, pharmacodynamic biomarkers and prognostic biomarkers. The study provides forecast and estimates market for each type in terms of revenue during the forecast period. Each type has been further analyzed based on regional and country levels in terms of revenue.
The biomarkers market has further been segmented based on diseases indication such as cancer, cardiovascular disorders, neurological disorders, immunological disorders and other diseases. The study provides forecast and estimates market for each diseases indication in terms of revenue during the forecast period. Each diseases indication has been further analyzed based on regional and country levels in terms of revenue.
The biomarkers market has been segmented based on applications such as diagnostics development, drug discovery and development, personalized medicine, disease risk assessment and other Applications. The study provides forecast and estimates market for each application in terms of revenue during the forecast period. Each application has been further analyzed based on regional and country levels in terms of revenue.
In terms of geography, the biomarkers market has been segmented into regions such as North America, Europe, Asia Pacific and Rest of the World. The study provides a detailed view of country-level aspects of the market on the basis of application segments and estimates the market in terms of revenue during the forecast period.
The report also covers the complete competitive landscape of the global Biomarkers market with company profiles of key players such as:
- Singulex, Inc.
- Signosis, Inc.
- Meso Scale Diagnostics, LLC.
- Biosims Technologies
- Qiagen N.V.
- Merck & Co, Inc.
- ENZO Biochem, Inc.
- EKF Diagnostics Holdings, Inc.
- Bio-Rad Laboratories, Inc.
- Perkinelmer, Inc.
- Cisbio Bioassays
A detailed description of the each company has been included and includes information in terms of headquarters, inception, stock listing, upcoming capacities, key mergers & acquisitions, financial overview, and recent developments provides a thorough idea about the competitive positioning of market players. The report also provides biomarkers market's mergers/acquisitions, partnerships, collaborations, new product launches, new product developments and other industry developments.
SEGMENTATIONS IN REPORT:
Biomarkers Market By Product:
- Consumables
- Services
- Software
Biomarkers Market By Type:
- Safety Biomarkers
- Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostic Biomarkers
- Validation Biomarkers
Biomarkers Market By Disease Indication:
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Immunological Disorders
- Other Diseases
Biomarkers Market By Applications:
- Diagnostics Development
- Drug Discovery and Development
- Personalized Medicine
- Disease Risk Assessment
- Other Applications
Biomarkers Market By Geography:
- North America
- Europe
- Asia Pacific
- Rest of the World
The Global Biomarkers Market has been exhibited in detail in the following chapters -
Chapter 1 Biomarkers Market Preface
Chapter 2 Executive Summary
Chapter 3 Biomarkers Industry Analysis
Chapter 4 Biomarkers Market Value Chain Analysis
Chapter 5 Biomarkers Market Analysis By Product
Chapter 6 Biomarkers Market Analysis By Type
Chapter 7 Biomarkers Market Analysis By Disease Indication
Chapter 8 Biomarkers Market Analysis By Applications
Chapter 9 Biomarkers Market Analysis By Geography
Chapter 10 Competitive Landscape Of Biomarkers Companies
Chapter 11 Company Profiles Of Biomarkers Industry
METHODOLOGY:
Combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific Details on methodology used for this report can be provided on demand.